Staar Surgical Co
STAAStock
$28.98+69.04%52W
Market Cap$1.37B
P/E—
Div yield—
Beta1.23
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)18.98%
Price vs S&P 500 (4W)-2.05%
VGM Score52.85
Market Capitalization$1.37B
Earnings Surprise History
Q1 260.23est. -0.07
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.47
3.53
3.65
3.65
Industry Peers — Ophthalmic Goods(8)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
STAAStaar Surgical Co | D | C | B | $28.98 |
| ALCAlcon Inc. Ordinary Shares | C | C | C | $70.62 |
| COOThe Cooper Companies, Inc. Common Stock | C | C | C | $73.10 |
| BLCOBausch + Lomb Corporation | B | D | C | $16.81 |
| WRBYWarby Parker Inc. | D | B | B | $27.59 |
| EYENational Vision Holdings, Inc. Common Stock | B | D | C | $20.80 |
| RXSTRxSight, Inc. Common Stock | B | D | D | $5.57 |
| LUCYInnovative Eyewear, Inc. Common Stock | A | A | D | $0.87 |
| LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27 | — | — | B | $0.06 |
About
STAAR Surgical Co manufactures Implantable Collamer Lenses (ICL) and delivery systems for refractive eye surgery. The company derives nearly all revenue from ICL sales, which are used to correct myopia and other refractive errors. A substantial portion of revenues comes from international markets.